Author response: Cap-independent co-expression of dsRNA-sensing and NF-κB pathway inhibitors enables tunable self-amplifying RNA expression with reduced immunotoxicity
Publicado em: 2025-7-15
Ajuste sua experiência de navegação
Tamanho da Fonte
100%